Participation in National Diabetes Prevention Program Is Cost-Saving
By Lori Solomon HealthDay Reporter
TUESDAY, Jan. 7, 2025 -- Participants with prediabetes enrolled in the National Diabetes Prevention Program (NDPP) have a reduction in direct medical costs over two years, according to a study published online Nov. 20 in Diabetes Care.
Shihchen Kuo, from the University of Michigan in Ann Arbor, and colleagues evaluated the real-world cost-effectiveness of the NDPP. The analysis included individual-level health insurance claims and survey data for 5,948 adults with prediabetes who enrolled (575 individuals) or did not enroll (5,373 individuals) in the NDPP.
The researchers found that compared with nonenrollees, each NDPP enrollee had an average reduction of $4,552 in two-year total direct medical costs. Hospitalizations, outpatient visits, and emergency room visits drove cost savings. There were no significant differences between the groups for EuroQol 5-Dimension 5-level questionnaire utility scores or quality-adjusted life-years (QALYs) gained over two years. Enrollment in the NDPP had an 88 percent probability of saving money and 84 percent probability of being cost-effective at a willingness-to-pay threshold of $100,000/QALY gained over two years.
"If delivered to a larger prediabetes population with longer-term follow-up, the NDPP could potentially reduce health care costs and improve QALYs for millions of American adults with prediabetes," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Opportunistic Community Screening IDs Uncontrolled Cardiovascular Risk Factors
FRIDAY, Aug. 15, 2025 -- Opportunistic pop-up community screening identifies a high prevalence of uncontrolled cardiovascular risk factors, according to a study published online...
Missed Opportunity Common in Patients With High-Grade Serous Ovarian Cancer
FRIDAY, Aug. 15, 2025 -- A considerable proportion of patients with high-grade serous cancer (HGSC) have missed opportunities for risk assessment with genetic testing and for...
EHR Notes Reveal Potential Racial Bias in Doctors' Perception of Patient Credibility
FRIDAY, Aug. 15, 2025 -- An analysis of more than 13 million electronic health record (EHR) notes shows potential racial bias in how doctors document patient trustworthiness...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.